Skip to main content
261 results

Supply disruption of varenicline has been on going since October 2021 because of the presence of nitrosamines above acceptable level of daily intake. There is still no certainty when varenicline will return.

A new ‘NICE real-world evidence framework’ was launched last week, with the aim to improve the quality of real-world evidence which informs NICE guidance development.

During 2021, IPCRG has been providing evidence based answers to the questions our global Sentinel Network of practising primary health care professionals ask about COVID.

Pre-emptively identifying patients with asthma most at risk for exacerbation and intervening to improve their asthma control has the potential to save lives.

Asking patients with respiratory disease about their use of candles and whether they have an attached garage may not be at the top of the list when conducting a regular reviews but perhaps it should be.

There are currently around 1.3 million people in the UK who have been diagnosed with COPD. It is a condition that affects the quality of life of those affected and can lead to premature death.

The PCRS Greener Respiratory Healthcare Pathway is the latest in a suite of tools available to support colleagues working in primary care to understand and deliver greener and more sustainable high quality respiratory healthcare that is kinder to environment.

PCRS is deeply concerned about the takeover of Vectura, a pharmaceutical company producing medicines for the treatment of respiratory disease, by Philip Morris International, a company whose tobacco products continue to cause addiction, suffering and death around the world.

Real life stories of how people’s health is damaged by social factors such as poor housing are being highlighted by nearly 200 organisations calling for a cross-government strategy to reduce health inequalities.

PCRS is currently seeking two new Trustees.  All interested applicants are invited to apply. In particular, we are looking for Trustees with background or experience in law (charity or commercial) and/or commercial/corporate partnerships and/or the pharmaceutical industry.

Alongside BTS, ERS, ATS and many other healthcare groups PCRS has submitted a letter to Vectura Board Members urging them to reject the acquisition offer by tobacco products manufacturer Philip Morris I

PCRS is delighted to announce that Simpson Millar has joined forces with PCRS to support our fantastic network of local respiratory groups – the PCRS Peer Support Network.

PCRS are proud to be part of the Media Planet’s Respiratory Health campaign - launched on 22nd June within the Guardian newspaper and online at https://bit.ly/3vuXRyV